Africa: Egypt’s Reme-D Gets $1.45m to Scale Molecular Diagnostics in Africa

Egyptian healthtech startup Reme-D has raised $1.45 million in a Pre-Series A funding round led by Anara Impact Capital to expand production of its molecular diagnostic tests and grow its presence across Africa and other underserved markets.

The round included participation from the Global Innovation Fund, Africa Health Ventures and other investors. The funding follows a $500,000 investment from the Global Innovation Fund in April and will support higher manufacturing capacity, regional expansion…